Synagis (palivizumab) / SOBI, AbbVie, AstraZeneca  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Synagis (palivizumab) / SOBI
NCT04540627 / 2020-001044-26: Exploratory Study to Estimate the Prophylactic Efficacy of Palivizumab in Healthy Adult Participants Inoculated With RSV

Completed
1
56
Europe
Palivizumab, Synagis™, Placebo, RSV-A Memphis 37b virus
mAbxience S.A
Healthy Adult Participants
10/20
10/20
NCT05121246: A PK Study Comparing MB05, EU-sourced Synagis® and US-sourced Synagis® in Healthy Volunteers.

Completed
1
150
RoW
MB05 (Proposed palivizumab biosimilar), EU-Synagis®, US-Synagis®
mAbxience Research S.L.
Healthy Volunteers
03/23
03/23

Download Options